Anafilaksi
Özet
Anafilaksi, tetikleyici etkenlere bağlı olarak dakikalar ve saatler içinde aniden gelişebilen, birden fazla organ sistemini aynı anda etkileyen ve tedavi edilmediği takdirde ölümle sonuçlanabilen en şiddetli sistemik aşırı duyarlılık reaksiyonudur. Tarihsel olarak ilk kez Charles Richet tarafından tanımlanan bu tablo, dünya genelinde gıda, ilaç ve böcek zehirleri gibi yaygın alerjenlerle tetiklenmekte ve prevalansı son yıllarda özellikle genç yaş gruplarında giderek artmaktadır. Patofizyolojik süreçte mast hücreleri ile bazofillerin degranülasyonu sonucu salınan kimyasal mediatörler; kapiller kaçağa, solunum yolu tıkanıklıklarına ve kardiyovasküler kollapsa yol açar. Mukokutanöz bulgulara eşlik eden solunum sıkıntısı, hipotansiyon veya gastrointestinal semptomlar klinik teşhiste belirleyicidir. Akut dönem yönetiminde ve tedavisinde ilk ve en kritik hayat kurtarıcı adım, intramüsküler adrenalin (epinefrin) uygulamasıdır. Solunum komplikasyonlarında oksijen desteği ve endotrakeal entübasyon, inatçı hipotansiyonda ise agresif sıvı resüsitasyonu ve beta-bloker kullanan hastalarda glukagon uygulaması gerekebilir. Akut atak sonrasında hastaların bir alerji uzmanına yönlendirilmesi, tetikleyicilerden uzak durma eğitimi almaları ve acil durumlar için yanlarında sürekli taşımak üzere kişisel otomatik adrenalin enjektörleri reçete edilmesi hayati önem taşır.
Anaphylaxis is the most severe systemic hypersensitivity reaction that develops rapidly within minutes to hours depending on specific triggers, affects multiple organ systems simultaneously, and can be fatal if left untreated. Historically identified by Charles Richet, this condition is commonly triggered worldwide by allergens such as food, medications, and insect venoms, and its prevalence has been rising significantly in recent years, particularly among younger age groups. Pathophysiologically, the degranulation of mast cells and basophils releases chemical mediators that induce capillary leakage, airway obstruction, and cardiovascular collapse. Diagnosis relies on mucocutaneous findings accompanied by respiratory distress, hypotension, or gastrointestinal symptoms. The first and most critical life-saving step in acute management is the intramuscular administration of adrenaline (epinephrine). Respiratory complications necessitate oxygen support or endotracheal intubation, whereas refractory hypotension requires aggressive fluid resuscitation and glucagon administration for patients on beta-blockers. Post-anaphylaxis care crucially involves referring patients to an allergy specialist, providing allergen avoidance counseling, and prescribing personal adrenaline auto-injectors that must be carried at all times for emergency self-administration.
Referanslar
Ring J, Brockow K, Behrendt H. History and classification of anaphylaxis. Novartis Found Symp. 2004;257:6-16.
Ghably J, Saleh H, Vyas H, et al. Paul Ehrlich’s mastzellen: a historical perspective of relevant developments in mast cell biology. Methods Mol Biol. 2015;1220:3-10. doi:10.1007/978-1-4939-1568-2_1
Centre for Clinical Practice at NICE (UK). Anaphylaxis: Assessment to Confirm an Anaphylactic Episode and the Decision to Refer After Emergency Treatment for a Suspected Anaphylactic Episode. Manchester (UK): National Institute for Health and Clinical Excellence (UK). 2011:1e95.
Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report e Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol. 2006;117(2):391e7. doi: 10.1016/j.jaci.2005.12.1303
Simons FE, Ardusso LR, Bilo MB, Cardona V, Ebisawa M, El-Gamal YM, et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J. 2014;7(1):9. doi: 10.1186/1939-4551-7-9
Castells M. Diagnosis and management of anaphylaxis in precision medicine. J Allergy Clin Immunol. 2017;140(2):321-33. doi: 10.1016/j.jaci.2017.06.012
Panesar SS, Javad S, de Silva D, et al. EAACI Food Allergy and Anaphylaxis Group. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy 2013;68(11):1353-61. doi: 10.1111/all.12272
Ma L, Danoff TM, Borish L. Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol. 2014; 133(4): 1075-1083. doi: 10.1016/j.jaci.2013.10.029
Lieberman P, Camargo CA Jr, Bohlke K, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol 2006;97(5):596e602. doi: 10.1016/S1081-1206(10)61086-1
Gupta R, Sheikh A, Strachan DP, et al. Time trends in allergic disorders in the UK. Thorax.2007;62(1):91-96. doi: 10.1136/thx.2004.038844
Poulos LM, Waters AM, Correll PK, et al. Trends in hospitalisations for anaphylaxis, angioedema and urticaria in Australia 1993-1994 to 2004-2005. J Allergy Clin Immunol. 2007;120(4):878-884. doi: 10.1016/j.jaci.2007.07.040
Jeppesen AN, Christiansen CF, Froslev T, et al. Hospitalization rates and prognosis of patients with anaphylactic shock in Denmark from 1995 through 2012. J Allergy Clin Immunol. 2016;137(4):1143-1147. doi: 10.1016/j.jaci.2015.10.027
Shen Y, Li L, Grant J, et al. Anaphylactic deaths in Maryland (US) and Shanghai (China): a review of forensic autopsy cases from 2004-2006. Forensic Sci Int. 2009;186(1-3):1-5. doi: 10.1016/j.forsciint.2008.12.007
Liew WK, Williamson E, Tang ML. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol. 2009;123(2):434-442. DOI: 10.1016/j.jaci.2008.10.049
Simons FE, Ardusso LR, Bilò MB, et al.; World Allergy Organization. World Allergy Organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2011; 4(2): 13-37. doi: 10.1097/WOX.0b013e318211496c
LoVerde D, Iweala OI, Eginli A, Krishnaswamy G. Anaphylaxis. Chest. 2018;153(2):528-543. doi:10.1016/j.chest.2017.07.033
Australasian Society of Clinical Immunology and Allergy. Acute management of anaphylaxis. (Accessed September 18, 2022. https:// www.allergy.org.au/hp//papers/acute-management-of-anaphylaxis-guidelines )
Tang AW. A practical guide to anaphylaxis [published correction appears in Am Fam Physician. 2004 Mar 1;69(5):1049]. Am Fam Physician. 2003;68(7):1325-1332.
LoVerde D, Files DC, Krishnaswamy G. Angioedema. Crit Care Med. 2017;45(4):725-735. doi: 10.1097/CCM.0000000000002281
Campbell RL, Li JT, Nicklas RA, et al. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol. 2014;113(6):599-608. doi: 10.1016/j.anai.2014.10.007
Sclar DA, Lieberman PL. Anaphylaxis: underdiagnosed, underreported, and undertreated. Am J Med. 2014;127(1): S1-S5. doi: 10.1016/j.amjmed.2013.09.007
Ring J, Brockow K, Behrendt H. History and classification of anaphylaxis. Novartis Found Symp. 2004;257:6-16.
Simons FE, Ebisawa M, Sanchez-Borges M, et al. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J. 2015;8(1):32. doi: 10.1186/s40413-015-0080-1
Lieberman P, Nicklas RA, Randolph C, et al. Anaphylaxis–a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115(5): 341-384. doi: 10.1016/j.anai.2015.07.019
Pumphrey RS. Fatal posture in anaphylactic shock. J Allergy Clin Immunol. 2003;112(2):451-452. doi: 10.1067/mai.2003.1614.
Commins SP. Outpatient emergencies: anaphylaxis. Med Clin North Am. 2017;101(3):521-536. doi: 10.1016/j.mcna.2016.12.003
Muraro A, Roberts G, Worm M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026-1045. doi: 10.1111/all.12437
Thomas M, Crawford I. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on betablockers. Emerg Med J. 2005;22(4):272-273. doi: 10.1136/emj.2005.023507
